Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Bioaraba (18)

2024

  1. Genetically engineered loaded extracellular vesicles for drug delivery

    Trends in Pharmacological Sciences, Vol. 45, Núm. 4, pp. 350-365

  2. Laponite nanoclays for the sustained delivery of therapeutic proteins

    European Journal of Pharmaceutical Sciences, Vol. 201

  3. Modulating the immune system towards a functional chronic wound healing: A biomaterials and Nanomedicine perspective

    Advanced Drug Delivery Reviews, Vol. 210

  4. PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy

    Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2788-2803

2023

  1. Agar/gelatin hydro-film containing EGF and Aloe vera for effective wound healing

    Journal of Materials Chemistry B, Vol. 11, Núm. 29, pp. 6896-6910

  2. Colistin- and amikacin-loaded lipid-based drug delivery systems for resistant gram-negative lung and wound bacterial infections

    International Journal of Pharmaceutics, Vol. 635

  3. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  4. High resolution and fidelity 3D printing of Laponite and alginate ink hydrogels for tunable biomedical applications

    Biomaterials Advances, Vol. 149

  5. Soy protein/β-chitin sponge-like scaffolds laden with human mesenchymal stromal cells from hair follicle or adipose tissue promote diabetic chronic wound healing

    Biomaterials Advances, Vol. 155

  6. Tumour-derived extracellular vesicle based vaccines for melanoma treatment

    Drug Delivery and Translational Research, Vol. 13, Núm. 5, pp. 1520-1542

2022

  1. Bioactive and degradable hydrogel based on human platelet-rich plasma fibrin matrix combined with oxidized alginate in a diabetic mice wound healing model

    Biomaterials Advances, Vol. 135

  2. Cell-based dressings: A journey through chronic wound management

    Biomaterials Advances, Vol. 135

  3. Clinical progress in MSC-based therapies for the management of severe COVID-19

    Cytokine and Growth Factor Reviews

  4. Dual effect of TAT functionalized DHAH lipid nanoparticles with neurotrophic factors in human BBB and microglia cultures

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

  5. Extracellular vesicles from hair follicle-derived mesenchymal stromal cells: isolation, characterization and therapeutic potential for chronic wound healing

    Stem Cell Research and Therapy, Vol. 13, Núm. 1

  6. Human Hair Follicle-Derived Mesenchymal Stromal Cells from the Lower Dermal Sheath as a Competitive Alternative for Immunomodulation

    Biomedicines, Vol. 10, Núm. 2

  7. Mesenchymal stromal cells encapsulated in licensing hydrogels exert delocalized systemic protection against ulcerative colitis via subcutaneous xenotransplantation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 172, pp. 31-40

2021

  1. Mesenchymal stromal cell secretome for the treatment of immune-mediated inflammatory diseases: Latest trends in isolation, content optimization and delivery avenues

    Pharmaceutics, Vol. 13, Núm. 11